oxazepam has been researched along with alprazolam in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.70) | 18.7374 |
| 1990's | 7 (15.22) | 18.2507 |
| 2000's | 11 (23.91) | 29.6817 |
| 2010's | 16 (34.78) | 24.3611 |
| 2020's | 8 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, RJ; Gall, M; Kamdar, BV | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ganeshpurkar, A; Gupta, SK; Gutti, G; Krishnamurthy, S; Kumar, D; Modi, G; Singh, SK | 1 |
| Rai, SN; Shankar, S; Sharma, P; Shrivastava, SK; Singh, SP; Srivastava, P; Srivastava, RK; Tripathi, PN | 1 |
| Sharma, P; Shrivastava, SK; Srivastava, P; Tripathi, PN | 1 |
| Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
| Carmona, AV; Kumari, S; Tiwari, AK; Trippier, PC | 1 |
| Jaiswal, S; Raja Ayyannan, S; Tiwari, V; Uniyal, A | 1 |
| Loeffler, PM | 1 |
| Kalli, A; Koskinen, T; Kultalahti, ER; Lepola, U; Naarala, M; Rimón, R; Tick, E | 1 |
| Krsiak, M; Sulcova, A | 1 |
| Ayd, FJ | 1 |
| Ciancio, SG | 1 |
| Pöldinger, W | 1 |
| Jalkanen, E; Väisänen, E | 1 |
| Jenck, F; Martin, JR; Moreau, JL | 1 |
| Needleman, SB; Porvaznik, M | 1 |
| Hemmersbach, P; Ragnar Norli, H; Rasmussen, KE; Reubsaet, KJ | 1 |
| Collins, DC; Lee, ML | 1 |
| Dickson, SJ; Irving, RC | 1 |
| Clampitt, DM; Goeders, NE; Guerin, GF; Keller, C; Sharma, M | 1 |
| Dai, Z; Liang, X; Liu, W | 1 |
| Chronister, CW; Goldberger, BA; Merves, ML | 1 |
| Marin, SJ; McMillin, GA | 1 |
| Gunn, J; Kriger, S; Terrell, AR | 1 |
| Grahovac, T; Rakun, R; Ružić, K; Sabljić, V | 1 |
| Bertol, E; Boscolo Berto, R; Favretto, D; Mannaioni, G; Mari, F; Vaiano, F | 1 |
| Goeders, NE; Guerin, GF; Spence, AL | 2 |
| Buckley, NA; Cairns, R; Pearson, SA; Schaffer, AL | 1 |
| Concheiro, M; Cruz, A; de-Castro-Ríos, A; Lendoiro, E; López-Rabuñal, A; López-Rivadulla, M | 1 |
| Falcon, M; Fernadez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, M | 1 |
| Johannsen, ML; Jørgensen, FS; Munkboel, CH; Styrishave, B | 1 |
| Madsen, BK; Møller, AM; Rosenberg, J; Zetner, D | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
5 review(s) available for oxazepam and alprazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.
Topics: Amides; Carbamates; Click Chemistry; Drug Design; Pyridines; Structure-Activity Relationship; Triazoles; Urea | 2020 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Oxazepam: update 1989.
Topics: Aged; Alcoholism; Alprazolam; Female; Humans; Oxazepam; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Melatonin for preoperative and postoperative anxiety in adults.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Anxiety; Bias; Clonidine; Drug Administration Schedule; Humans; Melatonin; Midazolam; Middle Aged; Oxazepam; Postoperative Care; Postoperative Complications; Preoperative Care; Publication Bias; Randomized Controlled Trials as Topic; Surgical Procedures, Operative | 2020 |
3 trial(s) available for oxazepam and alprazolam
| Article | Year |
|---|---|
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam; Psychiatric Status Rating Scales | 1991 |
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotic Disorders; Oxazepam; Random Allocation | 1985 |
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxazepam; Random Allocation | 1987 |
38 other study(ies) available for oxazepam and alprazolam
| Article | Year |
|---|---|
Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Hydroxylation; Male; Methods; Mice; Oxidation-Reduction; Triazolam; Triazoles | 1978 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Diketopiperazines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Matrix Metalloproteinase 2; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
Topics: Antioxidants; Benzoxazoles; Cholinesterase Inhibitors; Drug Design; Humans; Learning; Memory; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2019 |
Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Drug Design; Humans; Oxidative Stress | 2019 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
Topics: Amidohydrolases; Analgesics; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Monoacylglycerol Lipases; Neuralgia; Semicarbazones | 2022 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam | 1990 |
Drugs in dentistry. Agents for anxiety disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Dental Care; Diazepam; Humans; Oxazepam | 1985 |
Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.
Topics: Administration, Oral; Alprazolam; Animals; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Female; Flumazenil; Flunitrazepam; Male; Muscle Relaxation; Oxazepam; Saimiri; Sleep; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1995 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Determination of benzodiazepines in human urine and plasma with solvent modified solid phase micro extraction and gas chromatography; rationalisation of method development using experimental design strategies.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Diazepam; Flunitrazepam; Humans; Hydrogen-Ion Concentration; Models, Chemical; Nordazepam; Oxazepam; Research Design | 1998 |
Electrospray ionization gas-phase electrophoresis under ambient conditions and it's potential or high-speed separations.
Topics: Alprazolam; Anti-Anxiety Agents; Combinatorial Chemistry Techniques; Diazepam; Electrophoresis; Equipment Design; Herbicides; Nitrazepam; Oxazepam; Prazepam; Time Factors; Triazines | 2001 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Alprazolam and oxazepam block the cue-induced reinstatement of extinguished cocaine seeking in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Addictive; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Oxazepam; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration | 2009 |
[Simultaneous determination of 5 sedative hypnotics in human plasma by reversed phase high-performance liquid chromatography].
Topics: Alprazolam; Chromatography, High Pressure Liquid; Diazepam; Estazolam; Humans; Hypnotics and Sedatives; Nitrazepam; Oxazepam | 2009 |
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam | 2010 |
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Clonazepam; Flurazepam; Humans; Infant, Newborn; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazolam | 2010 |
Simultaneous determination and quantification of 12 benzodiazepines in serum or whole blood using UPLC/MS/MS.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Chromatography, Liquid; Clonazepam; Flunitrazepam; Humans; Lorazepam; Midazolam; Nordazepam; Oxazepam; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Duloxetine-related panic attacks.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Middle Aged; Oxazepam; Panic Disorder; Thiazepines; Thiophenes | 2011 |
A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: determination of MDPV metabolites by LC-HRMS and discussion of the case.
Topics: Adult; Alprazolam; Benzodiazepines; Benzodioxoles; Chlordiazepoxide; Chromatography, Liquid; Diazepam; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Nordazepam; Oxazepam; Psychotropic Drugs; Pyrrolidines; Substance-Related Disorders; Synthetic Cathinone; Temazepam | 2014 |
Differential modulation of the discriminative stimulus effects of methamphetamine and cocaine by alprazolam and oxazepam in male and female rats.
Topics: Alprazolam; Animals; Cocaine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Female; GABA Modulators; Male; Methamphetamine; Oxazepam; Rats; Rats, Wistar; Sex Factors | 2016 |
Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Diazepam; Drug and Narcotic Control; Drug Substitution; Female; Humans; Hypnotics and Sedatives; Interrupted Time Series Analysis; Male; Middle Aged; Oxazepam; Practice Patterns, Physicians' | 2016 |
The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats.
Topics: Alprazolam; Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Flumazenil; Isoquinolines; Male; Methamphetamine; Oxazepam; Premedication; Rats; Rats, Wistar; Receptors, GABA-A; Self Administration | 2016 |
LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium.
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Chromatography, Liquid; Clonazepam; Forensic Toxicology; Humans; Limit of Detection; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Zolpidem | 2020 |
Postmortem Analysis of Benzodiazepines in Human Bone by Gas Chromatography-Mass Spectrometry.
Topics: Alprazolam; Autopsy; Benzodiazepines; Chromatography, Liquid; Clonazepam; Diazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Liquid-Liquid Extraction; Lorazepam; Nordazepam; Oxazepam; Tandem Mass Spectrometry | 2021 |
Is the unique benzodiazepine structure interacting with CYP enzymes to affect steroid synthesis in vitro?
Topics: Adrenal Cortex Hormones; Adrenal Glands; Alprazolam; Androgens; Benzodiazepines; Diazepam; Endocrine Disruptors; Humans; Molecular Docking Simulation; Oxazepam; Receptors, Androgen; Receptors, GABA-A; Steroid 17-alpha-Hydroxylase; Steroid 21-Hydroxylase; Steroids | 2021 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |